Skip to main content

Find Clinical Trials

Home
Conditions
Measles

Clinical trial condition

Measles

Explore clinical trials studying Measles. Study availability and eligibility vary by location and protocol.

84 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Measles trial results

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life

NCT01681992

Conditions: Infections, Measles, Measles-Mumps-Rubella Vaccine, +15 more
Locations: GSK Investigational Site Birmingham, Alabama, United States

GSK Investigational Site Phoenix, Arizona, United States

GSK Investigational Site Phoenix, Arizona, United States

GSK Investigational Site Jonesboro, Arkansas, United States

View all 81 locations

View Trial Details

Completed

Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine

NCT02880865

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +30 more
Locations: Research Institute for Tropical Medicine Manila, Philippines

View Trial Details

Completed

Study to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and Rubella

NCT03148990

Conditions: Infections, Measles, Mononegavirales Infections, +7 more
Locations: Centro de Estudos e Pesquisas em Moléstias Infecciosas Ltda (CPCLIN) Natal, Rio Grande do Norte, Brazil

Secretaria Municipal de Saúde do Estado do Rio de Janeiro Rio de Janeiro, Brazil

View Trial Details

Completed

Evaluation of an Infant Immunization Encouragement Program in Nigeria

NCT03870061

Conditions: Actinomycetales Infections, Arbovirus Infections, Bacterial Infections, +55 more
Locations: Primary Health Care facilities across Jigawa State Various Cities, Jigawa State, Nigeria

Primary Health Care facilities across Katsina State Various Cities, Katsina State, Nigeria

Primary Health Care facilities across the Zamfara State Various Cities, Zamfara State, Nigeria

View Trial Details

Completed

Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age

NCT00861744

Conditions: Infections, Measles, Measles-Mumps-Rubella Vaccine, +15 more
Locations: GSK Investigational Site Tuscaloosa, Alabama, United States

GSK Investigational Site Conway, Arkansas, United States

GSK Investigational Site Jonesboro, Arkansas, United States

GSK Investigational Site Little Rock, Arkansas, United States

View all 48 locations

View Trial Details

Completed

Immunogenicity & Safety of Bio Farma's Measles-Rubella (MR) Vaccine in Indonesian Infants (Bridging Study)

NCT04183114

Conditions: Congenital Rubella Infection, Infections, Measles, +8 more
Locations: Child Health Dept. Dr. Soetomo Hospital, School of Medicine Airlangga Univ. Surabaya, East Java, Indonesia

View Trial Details

Completed

Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda

NCT04177485

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +41 more
Locations: Not specified

View Trial Details

Completed

Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of Age

NCT01702428

Conditions: Infections, Measles, Mononegavirales Infections, +14 more
Locations: GSK Investigational Site Dothan, Alabama, United States

GSK Investigational Site Phoenix, Arizona, United States

GSK Investigational Site Fayetteville, Arkansas, United States

GSK Investigational Site Anaheim, California, United States

View all 90 locations

View Trial Details

Completed

Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds

NCT00892775

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: GSK Investigational Site Singapore

GSK Investigational Site Singapore

GSK Investigational Site Singapore

GSK Investigational Site Taipei, Taiwan

View Trial Details

Completed

Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)

NCT00092430

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: Not specified

View Trial Details